Centogene N.V.
DelistedCIK 1757097fmd_1B90ZAF5T2YP9QXQS9RV6SMFHPServices · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2017 to Dec 31, 2023, 19 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|
| Total revenues | 32 | 40 | 49 | 38 | 42 | 47 | 49 |
| Cost of revenue | 15 | 20 | 26 | 35 | 29 | 28 | 31 |
| Gross profit | 17 | 21 | 23 | 3 | 13 | 20 | 17 |
| Research and development | 6 | 6 | 10 | 15 | 19 | 17 | 12 |
| Selling, general and administrative | 15 | 26 | 32 | 45 | 53 | 43 | 45 |
| Operating income | (4) | (11) | (19) | (58) | (57) | (37) | (30) |
| Interest expense | 1 | 1 | 2 | 1 | 1 | 5 | 8 |
| Income before taxes | (5) | (12) | (21) | (60) | (57) | (39) | (35) |
| Income tax expense | 0 | (0) | 0 | 0 | (0) | 0 | 0 |
| Net income from continuing operations | (5) | (11) | (21) | (60) | (57) | (39) | (36) |
| Net income | (5) | (11) | (21) | (22) | (46) | (32) | (36) |